If you self-harm, you know that it can be soothing at the time and could be an instinctive reaction to pain without ...
As the holidays approach, be mindful of the risks and rewards surrounding celebrations. With proactive measures and community support, it is possible to enjoy this festive season free from the shadows ...
EAST LIVERPOOL, Ohio (MyValleyTributes) – Fonda R. Moffett, age 63, of East Liverpool, passed away on Friday, December 12, ...
(9926.HK) ("Akeso" or the "Company") announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global multicenter Phase III trial in gastric cancer evaluating cadonilimab, a first-in-class ...
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ivonescimab (a PD-1/VEGF bispecific ...
Wondering if Akeso is still a smart buy after its big run up, or if the best days are already priced in? You are not alone. That is exactly what we are going to unpack. The stock has cooled slightly ...
The “Gifting for Seniors” drive has been a yearly holiday event since 2020, but this is the most presents the program has ...
Summit Therapeutics has an incredibly promising cancer candidate in the pipeline. Madrigal Pharmaceuticals made a breakthrough that could drive strong results for years to come. 10 stocks we like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback